apoptosis signaling antibody array kit (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
93
Structured Review
Cell Signaling Technology Inc
apoptosis signaling antibody array kit
Apoptosis Signaling Antibody Array Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 17 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoptosis+signaling+antibody+array+kit/Stress+and+Apoptosis+Antibody+Sampler+Kit/us12239732-1017-3-14
Average 93 stars, based on 17 article reviews
Apoptosis Signaling Antibody Array Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 17 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoptosis+signaling+antibody+array+kit/Stress+and+Apoptosis+Antibody+Sampler+Kit/us12239732-1017-3-14
Average 93 stars, based on 17 article reviews
apoptosis signaling antibody array kit - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Control:Article Title: Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression Article Snippet: .. Screening for stress markers activated in cells treated with SSTN EGF1R peptide for 24 h relative to vehicle-treated (50 mM Hepes, pH 7.4) control cells was conducted as previously described ( ) using the PathScan Stress and Ab Array:Article Title: Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression Article Snippet: .. Screening for stress markers activated in cells treated with SSTN EGF1R peptide for 24 h relative to vehicle-treated (50 mM Hepes, pH 7.4) control cells was conducted as previously described ( ) using the PathScan Stress and Article Title: Anti-CD37 immunoconjugate and anti-CD20 antibody combinations Article Snippet: .. Pathscan stress and Article Title: Inhibiting IGF1R-mediated Survival Signaling in Head and Neck Cancer with the Peptidomimetic SSTN IGF1R Article Snippet: CellTiter-GLO, ApoTox-GLO, and Caspase3/7-GLO were purchased from Promega. .. PathScan Stress and Article Title: Suppression of RPL34 Inhibits Tumor Cell Proliferation and Promotes Apoptosis in Glioblastoma. Article Snippet: Accumulating evidence indicates Ribosomal protein 34 (RPL34) promotes tumor malignance and its expression is associated with poor prognosis in multiple cancer cells.. However, the physiological role and biological mechanism of RPL34 in glioblastoma (GBM) remain unclear.. Hence, this study aimed to investigate the expression and the role of RPL34 in GBM. Article Title: OTUB1 knockdown promotes apoptosis in melanoma cells by upregulating TRAIL expression Article Snippet: The cell lines were maintained at 37°C and 5% CO 2 in media supplemented with 10% fetal bovine serum (Welgene Inc, South Korea) and 1% of antibiotics (Gibco/Invitrogen, Carlsbad, CA). .. The PathScan Stress and Article Title: Ru(II)-Naphthoquinone complexes with high selectivity for triple-negative breast cancer. Article Snippet: Six new ruthenium(II) complexes with lapachol (Lap) and lawsone (Law) with the general formula [Ru(L)(P– P)(bipy)]PF6, where L = Lap or Law, P–P = 1,2’-bis(diphenylphosphino)ethane (dppe), 1,4’-bis(diphenylphosphino)butane (dppb), 1,1’-bis(diphenylphosphino)ferrocene (dppf) and bipy = 2,2’-bipyridine, were synthesized, fully characterized by elemental analysis, molar conductivity, NMR, cyclic voltammetry, UVvis, IR spectroscopies and three of them by X-ray crystallography.. All six complexes were active against breast (MCF-7 and MDA-MB-231) and prostate (DU-145) cancer cell lines with lower IC50 values than cisplatin.. Complex [Ru(Lap)(dppe)(bipy)]PF6 (1a) showed significant selectivity for MDA-MB-231, a model of triple-negative breast cancer (TNBC), as compared to the “normal-like” human breast epithelial cell line, MCF-10A. Article Title: Anti-CD37 immunoconjugate and anti-CD20 antibody combinations Article Snippet: .. Pathscan stress and Article Title: The leaving group in Au(I)-phosphine compounds dictates cytotoxic pathways in CEM leukemia cells and reactivity towards a Cys 2 His 2 model zinc finger. Article Snippet: Gold(I)–phosphine “auranofin-like” compounds have been extensively explored as anticancer agents in the past decade.. Although potent cytotoxic agents, the lack of selectivity towards tumorigenic vs. nontumorigenic cell lines often hinders further application.. Here we explore the cytotoxic effects of a series of (R3P)AuL compounds, evaluating both the effect of the basicity and bulkiness of the carrier phosphine (R = Et or Cy), and the leaving group L (Cl vs. dmap). Modification:Article Title: Suppression of RPL34 Inhibits Tumor Cell Proliferation and Promotes Apoptosis in Glioblastoma. Article Snippet: Accumulating evidence indicates Ribosomal protein 34 (RPL34) promotes tumor malignance and its expression is associated with poor prognosis in multiple cancer cells.. However, the physiological role and biological mechanism of RPL34 in glioblastoma (GBM) remain unclear.. Hence, this study aimed to investigate the expression and the role of RPL34 in GBM. MTT Assay:Article Title: Suppression of RPL34 Inhibits Tumor Cell Proliferation and Promotes Apoptosis in Glioblastoma. Article Snippet: Accumulating evidence indicates Ribosomal protein 34 (RPL34) promotes tumor malignance and its expression is associated with poor prognosis in multiple cancer cells.. However, the physiological role and biological mechanism of RPL34 in glioblastoma (GBM) remain unclear.. Hence, this study aimed to investigate the expression and the role of RPL34 in GBM. Radio Immunoprecipitation:Article Title: Suppression of RPL34 Inhibits Tumor Cell Proliferation and Promotes Apoptosis in Glioblastoma. Article Snippet: Accumulating evidence indicates Ribosomal protein 34 (RPL34) promotes tumor malignance and its expression is associated with poor prognosis in multiple cancer cells.. However, the physiological role and biological mechanism of RPL34 in glioblastoma (GBM) remain unclear.. Hence, this study aimed to investigate the expression and the role of RPL34 in GBM. Bicinchoninic Acid Protein Assay:Article Title: Suppression of RPL34 Inhibits Tumor Cell Proliferation and Promotes Apoptosis in Glioblastoma. Article Snippet: Accumulating evidence indicates Ribosomal protein 34 (RPL34) promotes tumor malignance and its expression is associated with poor prognosis in multiple cancer cells.. However, the physiological role and biological mechanism of RPL34 in glioblastoma (GBM) remain unclear.. Hence, this study aimed to investigate the expression and the role of RPL34 in GBM. Marker:Article Title: Suppression of RPL34 Inhibits Tumor Cell Proliferation and Promotes Apoptosis in Glioblastoma. Article Snippet: Accumulating evidence indicates Ribosomal protein 34 (RPL34) promotes tumor malignance and its expression is associated with poor prognosis in multiple cancer cells.. However, the physiological role and biological mechanism of RPL34 in glioblastoma (GBM) remain unclear.. Hence, this study aimed to investigate the expression and the role of RPL34 in GBM. cDNA Synthesis:Article Title: Suppression of RPL34 Inhibits Tumor Cell Proliferation and Promotes Apoptosis in Glioblastoma. Article Snippet: Accumulating evidence indicates Ribosomal protein 34 (RPL34) promotes tumor malignance and its expression is associated with poor prognosis in multiple cancer cells.. However, the physiological role and biological mechanism of RPL34 in glioblastoma (GBM) remain unclear.. Hence, this study aimed to investigate the expression and the role of RPL34 in GBM. Immunohistochemistry:Article Title: Suppression of RPL34 Inhibits Tumor Cell Proliferation and Promotes Apoptosis in Glioblastoma. Article Snippet: Accumulating evidence indicates Ribosomal protein 34 (RPL34) promotes tumor malignance and its expression is associated with poor prognosis in multiple cancer cells.. However, the physiological role and biological mechanism of RPL34 in glioblastoma (GBM) remain unclear.. Hence, this study aimed to investigate the expression and the role of RPL34 in GBM. Western Blot:Article Title: Suppression of RPL34 Inhibits Tumor Cell Proliferation and Promotes Apoptosis in Glioblastoma. Article Snippet: Accumulating evidence indicates Ribosomal protein 34 (RPL34) promotes tumor malignance and its expression is associated with poor prognosis in multiple cancer cells.. However, the physiological role and biological mechanism of RPL34 in glioblastoma (GBM) remain unclear.. Hence, this study aimed to investigate the expression and the role of RPL34 in GBM. Incubation:Article Title: Ru(II)-Naphthoquinone complexes with high selectivity for triple-negative breast cancer. Article Snippet: Six new ruthenium(II) complexes with lapachol (Lap) and lawsone (Law) with the general formula [Ru(L)(P– P)(bipy)]PF6, where L = Lap or Law, P–P = 1,2’-bis(diphenylphosphino)ethane (dppe), 1,4’-bis(diphenylphosphino)butane (dppb), 1,1’-bis(diphenylphosphino)ferrocene (dppf) and bipy = 2,2’-bipyridine, were synthesized, fully characterized by elemental analysis, molar conductivity, NMR, cyclic voltammetry, UVvis, IR spectroscopies and three of them by X-ray crystallography.. All six complexes were active against breast (MCF-7 and MDA-MB-231) and prostate (DU-145) cancer cell lines with lower IC50 values than cisplatin.. Complex [Ru(Lap)(dppe)(bipy)]PF6 (1a) showed significant selectivity for MDA-MB-231, a model of triple-negative breast cancer (TNBC), as compared to the “normal-like” human breast epithelial cell line, MCF-10A. Expressing:Article Title: The leaving group in Au(I)-phosphine compounds dictates cytotoxic pathways in CEM leukemia cells and reactivity towards a Cys 2 His 2 model zinc finger. Article Snippet: Gold(I)–phosphine “auranofin-like” compounds have been extensively explored as anticancer agents in the past decade.. Although potent cytotoxic agents, the lack of selectivity towards tumorigenic vs. nontumorigenic cell lines often hinders further application.. Here we explore the cytotoxic effects of a series of (R3P)AuL compounds, evaluating both the effect of the basicity and bulkiness of the carrier phosphine (R = Et or Cy), and the leaving group L (Cl vs. dmap). |